A simple £13 test could diagnose patients with Myalgic encephalopathy (ME)
A new £13 test that claims to be able to diagnose ME (Myalgic encephalopathy) patients will be presented today at London’s Invest in ME conference.
Studies in Australia had shown that between 60 and 70 per cent of sufferers have large numbers of bacteria called enterococci and streptococchi in their gut.
Prof Kenny De Meirleir, from Vrije University, in Brussels, who created the new test, said that these bacteria, in combination with metals like mercury, create high levels of a gas, Hydrogen Sulphate, in the body.
This then limits the body’s ability to produce energy and creates a build-up of acid which muscles find difficult to break down.
Prof De Meirleir, who has seen a positive result in 80 to 90 per cent of patients said: ‘If you do not have this bacteria, you do not have ME.’
He believes that many patients could be treated with a combination of a change in diet, probiotics and antibiotics.
The test will be available from the website of the manufacturers, Protea Biopharma, from Monday.
Myalgic encephalopathy (ME), also known as Chronic Fatigue Syndrome, and dubbed ‘yuppie flu’ can leave sufferers bedridden for years.
The condition affects around 250,000 people in Britain, is twice as common in women than men, and typically affects patients between the ages of 20 and 40.